BEtablocker Treatment After Acute Myocardial Infarction in Patients Without Reduced Left Ventricular Systolic Function
A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 2895 participants.
Also called NCT03646357
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 2,895 participants
- Sponsor
- Registry
-
NCT03646357
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- Norway
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT03646357. Randomized; no masking; primary purpose treatment. Start 2018-10-01 (actual); primary completion 2025-04-04 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- BEtablocker Treatment After Acute Myocardial Infarction in Patients Without Reduced Left Ventricular Systolic Function
- Acronym
- BETAMI
- Condition
- Acute Myocardial Infarction
- Condition
- Non-ST Elevation Myocardial Infarction
- Condition
- ST Elevation Myocardial Infarction
- Intervention (Other)
- Non-betablocker
- Intervention (Drug)
- Betablocker
- Lead sponsor
- Oslo University Hospital
- Collaborator
- Vestre Viken Hospital Trust
- Collaborator
- The Hospital of Vestfold
- Collaborator
- University of Oslo
- Collaborator
- Helse Stavanger HF
- Collaborator
- Haukeland University Hospital
- Collaborator
- St. Olavs Hospital
- Collaborator
- University Hospital of North Norway
- Collaborator
- Sorlandet Hospital HF
- Collaborator
- Norwegian University of Science and Technology
- Collaborator
- Sykehuset Innlandet HF
- Collaborator
- Nordlandssykehuset HF
- Collaborator
- Lovisenberg Diakonale Hospital
- Collaborator
- Diakonhjemmet Hospital
- Collaborator
- Ostfold Hospital Trust
Record details
- Record id
cardio:ct-nct03646357- Content hash
fb6c5673ee13a1a5bb46a881ae23b72631bbcdaceaadc4d552ef0ec72979f07d